Compare Medtronic PLC (MDT) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs GeneDx Holdings Corp — how do they compare? Medtronic PLC trades at $82.79 (market cap $106.61B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Medtronic PLC is far larger — about 59.2× GeneDx Holdings Corp's market cap, and Medtronic PLC pays a 3.46% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| MDT | WGS | |
|---|---|---|
Market Cap | $106.61B | $1.80B |
Sector | Health | Technology |
52-Week High | $105.35 | $167.51 |
52-Week Low | $73.75 | $34.51 |
Enterprise Value | $125.36B | $1.80B |
Dividend Yield | 3.46% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
